A total of 3598 patients with PsA (51% female subjects) and 13,913 (72% female subjects, 74% ACPA-positive) patients with RA were identified from the national quality register for inflammatory arthritides between 1st January 2020 and 30th September 2021 (Table 1). This evidence concerns the gene PRTN3 and rheumatoid arthritis.